DCMP relapse (defined by a decrease in LVEF by >10%, an increase in LV volume by >10%, a doubling of NT-proBNP level with an increase to >400 ng/L, or development of clinical signs of heart failure) was considered the primary outcome. The gene discussed is NPPB; the disease is heart failure.